Yahoo Web Search

Search results

  1. More than 50 years ago, WHO established the International Nonproprietary Name (INN) Expert Group/WHO Expert Committee on Specifications for Pharmaceutical Preparations, to assign nonproprietary names to medicinal substances, so that each substance would be recognized globally by a unique name.

  2. International Nonproprietary Names (INN) for biological and biotechnological substances (a review) 2022.

  3. International Nonproprietary Names (INN) are global names for medicines. They provide one reference generic name for each individual medicine that comes to market. What is an INN? The School of INN (International Nonproprietary Names) In 1950 WHO established the INN Programme to provide a common language for people all over the

  4. International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. General guidance

  5. Dec 31, 2018 · International Nonproprietary Names (INN) for biological and biotechnological substances (a review) 2019.

  6. Dec 31, 2013 · All INN Experts designated to select nonproprietary names have to agree to the name which is then first published as a proposed INN. During a four-month period, any person can forward comments, or lodge a formal objection to a name, e.g. on grounds of similarity with a trade-name.

  7. People also ask

  8. An important step in drug development is the assignment of an International Nonproprietary Name (INN) by the World Health Organization (WHO) that provides healthcare professionals with a unique and universally available designated name to identify each pharmaceutical substance.